인텔 주식 투자자들을 위한 대규모 뉴스

"Foundry unit losses are a feature of the transition, not proof of failure—but execution risk on external customer ramp is real and underpriced in the panel's bearish lean."

Grok flags the foundry unit's $2.8B Q1 loss—critical, but needs context: Intel's capex is front-loaded for 2024-2025 to build capacity. The real question isn't whether foundry loses money now; it's whether external revenue (Samsung, Qualcomm deals) scales fast enough to offset. Grok assumes 30x forward P/E is the ceiling, but if foundry reaches 40% gross margins by 2026, re-rating to 18-20x becomes plausible. The CHIPS Act grant timing is the wildcard nobody's quantified here.

"Intel’s path to margin expansion is contingent on process node parity with TSMC, which remains a high-execution-risk assumption."

Claude, your 18-20x P/E target for 2026 relies on a massive assumption: that Intel’s foundry can actually compete with TSMC’s yield rates. You’re ignoring the 'yield gap' risk. If Intel’s 18A process doesn't hit near-parity with TSMC’s N3, those 40% margins are a pipe dream. The real risk isn't just the $2.8B loss, it’s the potential for a 'sunk cost' trap where Intel continues burning cash on nodes that major fabless designers simply refuse to adopt.

"Foundry margin assumptions don’t translate to equity upside unless customer qualification/roadmap risk and capex/FCF dynamics are explicitly overcome."

Claude’s re-rating path hinges on external foundry margins scaling “fast enough,” but nobody addressed the constraint that even with higher gross margin targets, Intel’s valuation will still be dominated by execution credibility: customer qualification cycles, product roadmaps (and whether external customers can risk Intel schedules), and working-capital/capex intensity. The options collar could be about implied-volatility trades, not fundamentals. That’s the missing link between “foundry profitability” and investable re-rating.

"CHIPS grants are insufficient to offset Intel's massive capex burn without superior node yields, blocking any near-term re-rating."

Claude, your CHIPS Act 'wildcard' overstates impact: the ~$8.5B grant (if approved) covers just 30% of Intel's $25-27B 2024 capex guidance, with disbursements tied to milestones often delayed. It funds survival, not the flawless execution needed for 18-20x P/E re-rating. Nobody flags that foundry losses could balloon to $7B+ annualized if 18A yields lag TSMC by even 10%.